Skip to content
Disclosery

Northpond Ventures, LLC

Follow

13F filer, CIK 1911245, Bethesda, MD

Northpond Ventures, LLC reported $102,625,277 across 4 holdings for the quarter ended 2024-03-31, in a 13F-HR filed 2024-05-15.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-24-061943

Period
2024-03-31
Reported value
$103M
Holdings
4
Top 10 weight
100%
New
1
Sold out
0

Largest buys vs the previous quarter

SecurityShares changeApprox. value
KYTXnew+3,255,426$80.9M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

None.

Holdings, Q1 2024

Share positions as resolved from 13F-HR 0001104659-24-061943, largest first. % of portfolio is the value over $102,625,277, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
KYTXKYVERNA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: not reported; 2023Q1: not reported; 2023Q2: not reported; 2023Q3: not reported; 2023Q4: not reported; 2024Q1: 3,255,426 shares 3,255,426$80.9M78.8%newTimeline
VIGIL NEUROSCIENCE INCVIGIL NEUROSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: 4,214,498 shares; 2023Q1: 4,214,498 shares; 2023Q2: 4,214,498 shares; 2023Q3: 4,214,498 shares; 2023Q4: 4,214,498 shares; 2024Q1: 4,214,498 shares 4,214,498$14.4M14%0
CODEX DNA INCCODEX DNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: 9,844,130 shares; 2023Q1: 9,844,130 shares; 2023Q2: 9,844,130 shares; 2023Q3: 9,844,130 shares; 2023Q4: 9,844,130 shares; 2024Q1: 9,844,130 shares 9,844,130$4.33M4.22%0
CADLCANDEL THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q2: restricted; 2022Q3: restricted; 2022Q4: 1,935,215 shares; 2023Q1: 1,935,215 shares; 2023Q2: 1,935,215 shares; 2023Q3: 1,935,215 shares; 2023Q4: 1,935,215 shares; 2024Q1: 1,935,215 shares 1,935,215$3.06M2.98%0Timeline

How Q1 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-24-061943 base2024-05-15acceptance time not in the bulk data set